Ghana aims to eliminate onchocerciasis by 2030, but persistent transmission in areas like Kwanware-Ottou in Wenchi Health District (HD) poses challenges.
This research follows an earlier study in the Wenchi HD which showed that despite more than 27 years of community-directed treatment with ivermectin (CDTI) including three years of biannual treatment, there was still high microfilarial prevalence (36.6%), blackfly vector infectivity (6.7%) and seroprevalence (38%). The earlier study has delineated the focus of transmission within a 10km radius, encompassing the Kwanware-Ottou community, which has been identified as a high-transmission area. The main contributing factors were related to CDTI, including remote settlements, mobile populations and questionable treatment records.
In this study a mixed-method approach was used to identify strategies to improve CDTI. The approach involved community consultations, use of satellite imagery to identify settlements, qualitative assessments and an updated census which included questions on treatment history.
The results of this study will inform potential scale up/ adoption of such investigatory and participatory approaches in areas with unsatisfactory progress towards elimination.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.